Evaluation to Assess Safety and Tolerability of DM199 in Subjects With Acute Ischemic Stroke
Status:
Completed
Trial end date:
2020-01-23
Target enrollment:
Participant gender:
Summary
This is a Phase II study to assess the safety and tolerability of DM199 in acute ischemic
stroke patients. The study will be randomized, placebo controlled at multiple centers.